Human tumor antigens recognized by an autologous host have been identified, and the list of antigens recognized by CD8 T cells (9,25,36,37), CD4 T cells (3,10,24,39), and antibodies (8,21,26) is rapidly growing. They can be categorized into the following groups: differentiation antigens (2,5,14), mutational antigens (27), amplified/over-expressed antigens (23), splice variant antigens (26, 28), viral antigens (16, 33), and cancer/testis (CT) antigens (4, 26). CT antigens have received particular attention because of their unique expression pattern and potential as targets for cancer vaccines (29,41). The characteristics of CT antigens include high levels of expression in male germ cells, lack of expression in other normal tissues, and aberrant expression in a wide range of tumors. There are now more than 20 genes or gene families known to code for CT antigens (29, 41).The identification of CT antigens has been primarily based on the detection of the candidate antigen/gene in tumors followed by their characterization using a panel of normal tissues and various tumors. The testis-specific expression of CT antigens may prompt one to investigate whether previously defined sperm proteins are also expressed in tumors. We have been studying the expression in tumors of proacrosin binding protein sp32 precursor present in spermatozoa (22) and A-kinase anchoring protein 3 (AKAP3) present in the sperm head and flagellum (7). Real-time RT-PCR analysis using a TaqMan probe showed mRNA over-expression associated with those sperm proteins in some tumors compared to corresponding normal tissues. In this study, we investigated TSGA10 mRNA expression in normal tissues and tumors. TSGA10 was originally identified by differential mRNA display as a testis-specific gene (18,19). Quantitative real-time RT-PCR analysis showed over-expres-
Editor-Communicated Paper
Over-Expression of the Testis-Specific Gene